Sabine Mai
Founder en TELO GENOMICS CORP. .
Fortuna: 233 266 $ al 31/03/2024
Perfil
Sabine Mai is the founder of Telo Genomics Corp.
which was founded in 2011.
She holds the title of Director at Telo Genomics Corp.
Dr. Mai's current jobs include being a Director at The Genomic Centre For Cancer Research & Diagnosis and a Professor at the University of Manitoba.
Dr. Mai's former job was being a Director at 3D Signatures, Inc.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
TELO GENOMICS CORP.
3.95% | 08/12/2023 | 2 810 433 ( 3.95% ) | 233 266 $ | 31/03/2024 |
Cargos activos de Sabine Mai
| Empresas | Cargo | Inicio |
|---|---|---|
| TELO GENOMICS CORP. | Founder | 25/05/2011 |
| University of Manitoba | Corporate Officer/Principal | - |
| The Genomic Centre For Cancer Research & Diagnosis | Director/Board Member | - |
Antiguos cargos conocidos de Sabine Mai.
| Empresas | Cargo | Fin |
|---|---|---|
3D Signatures, Inc. /Old/
 3D Signatures, Inc. /Old/ Medical/Nursing ServicesHealth Services 3D Signatures, Inc. develops diagnostic and prognostic products. It provides diagnostic and prognostic tools for cancer and Alzheimer's disease. 3D Signatures is in the process of developing 3D Telo-PC for prostate cancer and 3D Telo-RS for Hodgkin’s Lymphoma. The company is headquartered in Winnipeg, Canada. | Director/Board Member | - |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| TELO GENOMICS CORP. | Health Services |
| Empresas privadas | 2 |
|---|---|
3D Signatures, Inc. /Old/
3D Signatures, Inc. /Old/ Medical/Nursing ServicesHealth Services 3D Signatures, Inc. develops diagnostic and prognostic products. It provides diagnostic and prognostic tools for cancer and Alzheimer's disease. 3D Signatures is in the process of developing 3D Telo-PC for prostate cancer and 3D Telo-RS for Hodgkin’s Lymphoma. The company is headquartered in Winnipeg, Canada. | Health Services |
| The Genomic Centre For Cancer Research & Diagnosis |
- Bolsa de valores
- Insiders
- Sabine Mai
